drugset / Trial / NCT00366444

Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery

NCT00366444

Phase 3 Completed 201 enrolled Xanodyne Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

A multicenter study to evaluate the analgesic efficacy of XP21L in subjects with pain following bunionectomy surgery.

Timeline

Start
2006-08
Primary completion
2006-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 25 mg

Indications